Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes    Leukemias    Solid Tumours    Cancer-Prone    Deep Insight    Case Reports    Journals   Portal    Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
    

Upstream Signal Transduction of NF-kB Activation

Fei Chen§, Jacquelyn Bower, Laurence M. Demers¶, and Xianglin Shi

The Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, USA; ¶Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA


§ To whom correspondence should be addressed at:
Dr. Fei Chen PPRB/NIOSH, 1095 Willowdale Road, Morgantown, WV 26505
Tel: (304) 285-6021, Fax: (304) 285-5938, E-mail: lfd3@cdc.gov

December 2001

 

 

 

Abstract

NF-kB is a transcription factor governing the expression of genes involved in the immune response, embryo or cell lineage development, cell apoptosis, cell cycle progression, inflammation, and oncogenesis. During past few years, tremendous attention has been focused on the upstream signaling pathways leading to the activation of this transcription factor. Many of these signaling molecules can serve as potential pharmaceutical targets for the specific inhibition of NF-kB activation and the subsequent interference of disease processes. However, how these molecules interact with each other is still a debatable issue. Since many nodal signal molecules in this pathway relay more than one of the upstream signals to their downstream targets, it has been speculated that the transmission of signals involves a network, rather than a linear sequence in the activation of NF-kB. Thus, elucidation of the detailed relationships among the upstream signaling molecules of NF-kB activation will be important in developing pharmaceutical inhibitors that specifically inhibit the activation of NF-kB. Such inhibitors would be predicted to have powerful anti-inflammatory and/or anti- carcinogenic effects.

 

Key words: IKK, kinases, NF-kB, ROIs, signal transduction, ubiquitination.

The NF-kB transcription factor was first discovered in 1986 . Knowledge of the activation of this transcription factor lagged behind the understanding of its function. Nevertheless, tremendous progress has been achieved over the last two years regarding the signal transduction pathways leading to the activation of NF-kB including the structure and function of IkB kinase complexes (IKK)1, the upstream signaling pathways, the interactions among diverse signaling components, and the extracellular regulators .

At present, five mammalian NF-kB family members have been identified and cloned . These include NF-kB1 (p50/p105), NF-kB2 (p52/p100), RelA(p65), RelB, and c-Rel . All these NF-kB family members share a highly conserved Rel homology domain (RHD) responsible for DNA binding, dimerization, and interaction with IkB, the intracellular inhibitor of NF-kB. The C-terminal regions of RelA, RelB and c- Rel contain a transactivating domain that is important for NF-kB-mediated gene transactivation. The C-termini of the precursor molecules for p50 and p52, p105 and p100, contain multiple copies of the so-called ankyrin repeat, which is found in IkB family members, including IkBa, IkBb, IkBe, Bcl3, and Drosophila cactus.

Diverse stimuli, which typically include cytokines, mitogens, environmental and occupational hazards, toxic metals, intracellular stresses, viral or bacterial products, and UV light, induce expression of early response genes through the NF-kB family of transcription factors . In resting cells, NF-kB is sequestered in the cytoplasm in an inactive form through its association with one of several inhibitory molecules, including IkBa, IkBb, IkBe, p105, and p100. Activation of the NF-kB signaling cascade results in complete degradation of IkB or partial degradation of the C-termini of p105 and p100 precursors, allowing the translocation of NF-kB to the nucleus, where it induces transcription (Fig. 1). Activated NF-kB binds to the enhancer or promoter regions of target genes and regulates transcription of genes mediating cell-to- cell interaction, intercellular communication, cell recruitment or transmigration, amplification or spreading of primary pathogenic signals, and initiation or acceleration of carcinogenesis. The consensus binding site of NF-kB is composed of the GGGRNNYYCC sequence, where R is purine, Y is pyrimidine, and N is any bases.

Figure 1 : Simplified signal transduction pathways of NF-kB activation. Pro- inflammatory signals, mainly TNFa, IL-1 or Toll, bind to their corresponding receptors, leading to a recruitment of receptor-associated proteins, such as MyD88 and IRAK for IL-1R/TLR, TRADD and RIP1 for TNF receptor. In turn these associated proteins recruit TRAF2 or TRAF6, both of which activate TAK1 possibly through a non-destructive G76-K63 polyubiquitin chain-dependent mechanism (Ub63). Activated TAK1 or other MAPKKK family kinases, such as NIK and MEKK1, may phosphorylate and activate IKK complexes that are responsible for the phosphorylation of the IkB protein. Phosphorylated IkB proteins are recognized and modified by the G76-K48 polyubiquitin chain (Ub48) via the SCF-b-TrCP complex. This process is followed by proteasome-mediated degradation of IkBs. Stress signals resulting in the generation of ROIs contribute to the activation of NF-kB and may involve the sequential activation of ASK1, SEK1 and JNK. Activated JNK induces the accumulation of b-TrCP protein, which facilitates the ubiquitination process of IkB proteins.

I. IkB kinase complexes (IKK)

The expanding family of IKK, which includes the IKKa, IKKb, IKKg, and IKKi/e, has, over the past three years, been implicated in the phosphorylation of several IkB proteins and NF-kB family proteins, such as IkBa, IkBb, IkBg, IkBe, p105, p100, and RelA(p65) in response to numerous and diverse stimuli . In addition, some non-IkB/NF-kB family proteins, such as b-catenin and HIV vpu protein, have also been implicated as potential IKK substrates . All IkB proteins contain two conserved serine (S) residues within their N-terminal domain. Phosphorylation of these conserved S residues by IkB kinase (IKK) in response to inducers, leads to the immediate polyubiquitination of IkB proteins by SCF-b-TrCP, a ubiquitin ligase E3 complex . This modification subsequently targets IkB proteins for rapid degradation by the 26S proteasome . The first identified IKK complex, which is also the major IKK complex in most cell types, contains two catalytic subunits, IKKa and IKKb, and a structural component named NEMO/IKKg/IKKAP, which may relay upstream signals to IKK and possibly promote assembly of the IKK complex .

IKKa and IKKb share 50% sequence homology. Both proteins contain a N-terminal kinase domain, a C-terminal region with a leucine zipper, and a helix-loop-helix domain . An activation loop similar to the one found in the MAP-kinase kinase (MEK) family of proteins has been identified between the kinase subdomains VII and VIII of IKKa and IKKb. Studies by in vitro or ex vivo approaches indicate that both IKKa and IKKb are interchangeable in phosphorylating S32/S36 of IkBa, and S19/S23 of IkBb . However, substantial differences in function and regulation of IKKa and IKKb have been documented. First, IKKb is far more potent than IKKa in IkBa phosphorylation in response to proinflammatory stimuli, such as the signals induced by TNFa, IL-1 and LPS . Second, whereas IKKa seems to be more responsible for NF- kB-inducing kinase (NIK) signals, IKKb appears more important in mediating MEKK1 reactions . Third, gene knockout studies demonstrated that IKKa, but not IKKb, is physiologically involved in NIK-mediated carboxyl terminal phosphorylation and subsequent process of NF-kB2 (p100) precursor . Fourth, IKKa controls keratinocyte differentiation by a kinase-independent mechanism that affects the production of keratinocyte differentiation-inducing factor (kDIF) . IKKb, in contrast, is not necessary for this function. Finally, although both IKKa and IKKb can phosphorylate multiple regions of b-catenin, an opposite effect of IKKa and IKKb on the transcriptional activity and intracellular localization of b-catenin has been observed. Using mouse embryo fibroblasts (MEF) lacking IKKa or IKKb gene, Lamberti et al reported that IKKa increased the nuclear localization and transcriptional activity of b-catenin, whereas IKKb decreased the nuclear localization and transcriptional activity of b-catenin.

Limited information is available concerning another recently identified IKK complex, IKKi/e. In contrast to the original IKK complex, this new IKK complex does not contain IKKa, b or g . IKKi/e shares 27% homology with IKKa and IKKb and possibly mediates NF-kB-activating kinase (NAK) signaling, PMA/PKCε-induced S36 phosphorylation of IkBa, and NF-kB activation . In contrast to IKKa and IKKb, which are constitutively expressed in most cell types, the expression of IKKi/e is inducible. In the mouse macrophage cell line, RAW264.7, lipopolysaccharide (LPS) and some other NF-kB-inducing cytokines, can drastically induce the accumulation of IKKi/e mRNA . Intriguingly, none of these inducers seem to be able to stimulate the kinase activity of transfected IKKi/e. Yeast two-hybrid screening by Nomura et al. recently showed that the C- terminal portion of IKKi/e can specifically associate with the N-terminal domain of I-TRAF/TANK, an interaction protein of tumor necrosis factor receptor-associated factor. Thus, it is possible that IKKi/e either acts further upstream of IKKa/b or at the same hierarchical level of IKKa/b after its association with I-TRAF/TANK.

The predominant role of IKK is its activity as a serine/threonine kinase phosphorylating IkB family proteins . Most of IkB family proteins contain a conserved DSGXXS motif, where X is any amino acid . IKK is also able to phosphoyrlate NF-kB p65 protein on a non-consensus site, S536 . The ability of IKK to exert its profound kinase activity has led many intensive investigations to explore its likely role in other cellular responses. Homology searches of the gene bank protein sequence database reveal that a number of non-IkB/NF-kB family proteins also contain this motif. These proteins include b-catenin, HIV vpu protein, phosphoinositide 3- kinase enhancer (centaurin), c-Ski, Rho/Rac guanine nucleotide exchange factor, and a number of other potential substrates listed in table 1. Except for b-catenin, which has been recently demonstrated to be an IKK substrate , no experimental data so far suggests that IKK can phosphorylate these non-IkB/NF-kB family proteins. New evidence suggests that IKKa controls keratinocyte differentiation and IKKb attenuates insulin signaling related to type 2 diabetes and obesity . Thus, in addition to NF-kB signaling, IKK might be involved in several other cellular signal transduction pathways in either a kinase activity-dependent or a kinase activity-independent manner.

There are several good candidates for the inhibition of IKK activity. One group is the nonsteroidal anti- inflammatory drugs (NSAIDs), including aspirin and sodium salicylate. NSAIDs have been previously shown to inhibit activation of NF-kB and cytokine-induced mRNA of cell adhesion molecules . Later studies suggested that these effects of NSAIDs are the result of specific inhibition of ATP-binding to IKKb , which is independent of their cyclooxygenase- 2 (COX-2) inhibitory activity. A second candidate is the 15d- PGJ2, an anti-inflammatory cyclopentenone prostaglandin and a natural ligand for peroxisome proliferator-activated receptor g (PPARg) . In Jurkat T cells or HeLa cells, 15d-PGJ2 inhibits TPA- or TNFa-induced NF-kB activation in a PPARg-independent manner . A direct modification of cysteine 179 (C179) in the activation loop of IKKb by 15d-PGJ2 was observed in an in vitro IKK kinase activity assay . The IC50 for inhibition of IKK activity was around 5 mM. The same concentration of 15d- PGJ2, in contrast, stimulated JNK activity, indicating that 15d-PGJ2 or its analogs may have therapeutic potential for diseases in which inhibition of IKK and NF-kB may be desirable. However, it should be noted that the inhibitory effect of 15d-PGJ2 on IKK and NF- kB might be cell type or stimulus dependent. This becomes evident by the fact that 15d-PGJ2 potentiated LPS-induced gene expression of IL-8, a NF-kB targeting gene . The third group of IKK inhibitors includes several plant extracts that have been shown to reduce IKK activity in some experimental systems. These extracts include resveratrol, parthenolide, and green tea polyphenol (-)- epigallocatechin-3-gallate . The specificity and potential application of these natural products in inhibiting IKK activity remain to be investigated. Finally, two relatively specific IKK inhibitors are being developed by Signal Pharmaceuticals and Novartis Pharma AG, respectively. Signal Pharmaceuticals developed a selective IKKb inhibitor named SPC839 that inhibits IKKb with nanomolar potency and IKKa with micromolar potency.

  1. Upstream kinases of IKK

1. MEKK1

MEKK1 is a mammalian serine/threonine kinase in the mitogen-activated protein kinase kinase kinase (MAPKKK) group. It was found that MEKK1 was a far more important activator for JNK signaling rather than ERK signaling as was proposed originally . The first evidence indicating the involvement of MEKK1 in signal-induced IKK activation was provided by Lee et al. . In their studies, they reported that the addition of the recombinant catalytic domain of MEKK1 (MEKK1D ) to the partially enriched fraction of nonstimulated HeLa cells stimulated an IKK-like kinase activity that phosphorylated IkBa at S32 and S36 and subsequent ubiquitination and degradation of IkBa. Follow-up studies demonstrated that overexpression of MEKK1 stimulated the NF- kB-dependent transcriptional reporter . The activation of NF-kB by HTLV Tax protein was shown to require MEKK1 . MEKK1 may also contribute to Toll- and IL-1 receptor-mediated IKK activation, as demonstrated by an adaptor protein, known as evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) that could promote the proteolytic activation of MEKK1 and subsequent activation of NF-kB . Further studies by Mercurio et al. indicated the presence of a protein in the IKK complex that is recognized by anti-MEKK1 antiserum .

Although MEKK1 has been shown to contribute to IKK activation in a number of studies, the precise molecular link between these two kinases remains unclear. One intriguing possibility is that MEKK1 may directly phosphorylate both IKKa and IKKb at the MAPKK activation loop, 176/177 S-X-X-X-S 180/181, where X is any amino acid. Substitution of these serines with alanine residues inactivates both kinases, whereas phosphomimetic glutamic acid substitution at these positions results in constitutively active kinases . Nevertheless, it remains to be confirmed whether MEKK1 is a physiological activator of IKK in cells in response to various stimuli. Indeed, a recent study by Xia et al. demonstrated that inactivation of MEKK1 did not result in an impairment of NF-kB activation in response to TNFa, IL-1, LPS, and dsRNA.

2. NF-kB-Inducing Kinase (NIK)

NIK, a member of the MAPKKK family, was originally identified as a tumor necrosis factor (TNFa) receptor associating factor 2 (TRAF2)- interacting kinase whose overexpression results in potent NF-kB activation without any considerable effect on MAPKs . A study using yeast two-hybrid screens identified an interaction between NIK and IKK, suggesting that NIK might be a direct upstream activator of IKK . Transient transfection of NIK into human embryonic kidney 293 cells indicated that IKKa was more responsive to NIK, whereas IKKb was slightly more responsive to MEKK1 . When the abilities of MEKK1 and NIK to activate total IKK kinase activity are compared, most of studies show that NIK is a much stronger activator of the NF-kB transcriptional reporter than MEKK1. NIK could preferentially phosphorylate IKKa on Sl76 in the activation loop, leading to the activation of IKKa kinase activity. In contrast, MEKK1 was found to preferentially phosphorylate the corresponding serine residue, Sl77, in the activation loop of IKKb. A dominant negative mutant of NIK blocked NF- kB activation by TNFa, interleukin-1 (IL-1), Fas, Toll-like receptors 2 and 4 , LMP1 and CD3/CD28 stimulation . Thus, NIK appears to be a general kinase mediating IKK activation induced by diverse stimuli. However, a recent analysis using the NIK-mutant mouse strain alymphoplasia (aly) contradicted this assumption. The Alymohoplasia mouse strain failed to develop lymphoid organs, such as lymph nodes and Peyer's patches due to a point mutation in the NIK locus . The mutation of NIK locus results in disruption of interactions between NIK and IKKa or TRAF proteins. Further analysis indicated that the aly mutation did not affect TNFa-induced activation of NF- kB but only blocked lymphotoxin-mediated activation of NF-kB. Similarly, studies using cells derived from NIK-deficient mice have indicated that NIK appears to be dispensable in IKK activation induced by TNFa or IL-1 . Intriguingly, lymphotoxin b induced a normal NF-kB DNA-binding activity in NIK-deficient cells, whereas the same treatment failed to induce NF-kB reporter gene activity or NF-kB target gene expression . It raises the possibility that NIK may be specifically involved in IKK activation induced by lymphotoxin but not others.

3. NF-kB activating kinase (NAK)

Several groups independently identified a novel serine/threonine kinase, possibly activating IKK through direct phosphorylation in cells stimulated with PMA . This novel kinase was named NAK, TANK-binding-kinase 1 (TBK1), or T2K. Pomerantz and Baltimore cloned NAK by a yeast two-hybrid screen using the N- terminal stimulatory domain of TANK 1-190 fused to GAL4 as bait, and a human B-cell library fused to the GAL4 activation domain. The same kinase was also identified by PCR using degenerate primers based on sequences common to IKKa and IKKb . The amino acid sequence analysis indicated that the NAK protein contains a kinase domain at its N-terminus that exhibits about 30% identity to the corresponding kinase domains of IKKa and IKKb, and more than 60% identity to the corresponding kinase domain of IKKi/e. The report by Pomerantz and Baltimore showed that NAK might form a ternary complex with TANK and TRAF-2, suggesting that NAK functions to the far more upstream of the signal cascade leading to IKK activation, whereas in vitro kinase activation assay by Tojima and co-workers demonstrated that NAK was a direct upstream kinase phosphorylating IKKb. Interestingly, activation of endogenous NAK resulted in only S36, but not S32 phosphorylation of IkBa, a similar phenomenon observed in recombinant IKKi/e- mediated IkBa phosphorylation . Since both IKKa and IKKb are able to phosphorylate both S32 and S36 of IkBa protein, it is unclear whether IKKi/e or a novel IKK isozyme functions as a downstream kinase of NAK to induce S36 phosphorylation of IkBa. Transient transfection studies showed that dominant negative NAK inhibited NF- kB transcriptional reporter activity induced by PMA, PKCe, and PDGF, but not by TNFa, IL-1b, LPS, or ionizing radiation . These results, therefore, suggest that NAK is likely to be a downstream kinase of PKCe or related isozymes, and an upstream kinase of IKK in the signaling pathway through which growth factors, such as PDGF, stimulate NF-kB activity.

4. Akt (PKB)

The pro-survival function of Akt has been well documented. The kinase activity of Akt is activated via the phosphoinositide-3-OH kinase (Pl3K) and P13K-dependent kinase 1/2 (PDKI/2) signaling pathways . Overexpression or constitutive activation of Akt has been associated with tumorigenesis in a number of studies. As a serine/threonine kinase, Akt is able to phosphorylate the pro-apoptotic protein Bad, the anti-apoptotic protein Bcl-x, the apoptotic protease caspase-9, the Forkhead transcription factors, and eNOS . However, considerable controversy remains regarding the involvement of Akt in signal-induced IKK activation. Studies by Ozes et al. and Xie et al. indicated that Akt was required for TNFa- or G protein activator-induced NF-kB activation by directly phosphorylating and activating IKKa in 293, HeLa, and ME-180 cells. A putative Akt phosphorylation site at amino acids 18 to 23 in both IKKa and IKKb was identified. Akt induced T23 phosphorylation of IKKa both in vitro and in vivo. Mutation of T23 significantly decreased Akt-induced IKKa phosphorylation and TNFa-induced NF-kB activation in 293, HeLa, and ME-180 cells . By contrast, Romashkova et al. demonstrated that Akt was involved in PDGF-mediated, but not TNFa- or PMA-mediated NF-kB activation in human or rat fibroblasts. In this study, the authors suggested that upon PDGF stimulation, Akt could transiently associate with IKK and induce the activation IKK, especially IKKb. Several other studies, however, contradicting these reports, suggested that the effects of Akt on NF-kB did not occur at the level of IKK activation in several cell types. A study by Delhase and co- workers indicated that Akt activation induced by IGF-I failed to activate IKKa, IkBa phosphorylation and degradation, or NF-kB DNA binding in HeLa cells, the same cell line used by Ozes et al . Similarly, several recent studies showed that Akt was not involved in TNFa-induced NF-kB activation in human vascular smooth muscle cells, skin fibroblasts, or endothelial cells . Rather, Akt might enhance the ability of the p65 (RelA) transactivation to induce transcription . In Jurkat T-cells, Akt alone failed to activate NF-kB, but it was capable of potentiating NF-kB activation induced by PMA, partially by enhancing IkBb degradation . Evidence further supporting this notion is the observation that expression of constitutively active Akt upregulates the mRNA level of b-TrCP, a subunit of the SCF-b-TrCP complex responsible for the ubiquitination of IkBa or IkBb proteins . Thus, it is possible that Akt phosphorylates IKK in a cell context- and stimulation-dependent manner. It is also highly possible that several different mechanisms are involved in Akt-regulated NF-kB activation. One remaining question is whether or not upstream kinases of Akt, such as PDK1 and PDK2, also activate IKK, since both IKKa and IKKb contain a putative PDK1 phosphorylation site (S-F-X-G-T-X-X-Y-X-A-P-E) directly juxtaposed to the MAPKKK phosphorylation site .

5. Mixed-Lineage Kinase 3 (MLK3)

MLK3, another member of the MAPKKK family, contains an N-terminal SH3 domain, followed by the catalytic domain and two tandem leucine/isoleucine zippers, a basic region, a Cdc42/Rac binding motif, and a proline-rich C terminus . Based on these structural characteristics, MLK3 may associate with a variety of protein modules. Studies by Hehner et al. suggested that MLK3 could directly associate with IKK complex through its leucine zipper domain and phosphorylate Sl76 of IKKa and Sl77 and Sl8l of IKKb. Transfection of Jurkat T cells with a kinase- mutated form of MLK3 blocked CD3-CD28 signal- and PMA-induced NF-kB transcriptional activity. No significant influence of this mutated MLK3 was observed on either TNFa- or IL-1-induced NF-kB activation. These results suggest that MLK3 may be important in mediating T-cell co-stimulation-induced activation of IKK and consequent NF-kB-dependent transcription. MLK3 has also been shown to form a complex with a JNK scaffold protein JIP and stimulate JNK activation . Thus, MLK3 may function as an integral molecule between the signaling pathways leading to the activation of NF-kB and JNK, which would provide a molecular explanation why many stimuli induce NF-kB and JNK simultaneously under certain circumstances.

6. TGFb-Activated Kinase 1 (TAK1)

TAK1 is a member of the MAPKKK (MAP3K) family, which was originally identified as a kinase mediating the signaling pathway of TGFb superfamily members . Transfection of the cells with an activated form of TAK1, in which the N-terminal 22 amino acids are deleted, induces expression of a reporter gene governed by TGFb-responsive promoter . However, the biochemical link between TGFb and TAK1 has been elusive. Ironically, the contributions of TAK1 to signal-induced NF-kB and JNK activation have been studied intensively. Several new insights into the roles of TAK1 in IKK activation have emerged in the cellular response to cytokines or Toll signals . The first evidence to suggest that TAK1 is involved in NF- kB signaling came from studies in which overexpression of TAK1 together with its activator protein, TAK1 binding protein 1 (TAB1), induced the nuclear translocation of NF- kB in a NIK-independent manner . Further studies indicated a direct physiological interaction between TAK1 and IKK in unstimulated cells . Recruitment of TAB1 and/or TAB2 to TAK1 activates the kinase activity of TAK1, resulting in phosphorylation of the serine residues in the activation loop of IKK and subsequent dissociation of TAK1 from IKK complex . In Drosophila, a null mutation in the TAK1 gene produces phenotypes similar to that of mutations in immune deficiency (Imd), and IKK, suggesting that TAK1 is a direct kinase mediating Imd signals . Genetic studies and sequential chromatographic purification by Wang et al. demonstrate that the kinase activity of TAK1 in response to IL-1 is dependent on the TRAF6 protein, which has been modified by a distinct polyubiquitin chain assembled through the lysine 63 (K63) at each ubiquitin molecules. In contrast to the polyubiquitin chain in which the C-terminal glycine 76 (G76) of one ubiquitin is ligated to the K48 side chain of the neighboring ubiquitin, the polyubiquitin chain linked through G76-K63 does not target proteins for proteasomal degradation, but rather, activates the function of proteins (see below) . The major debatable issues in TAK1-induced IKK activation are the involvement and hierarchical position of NIK. Whereas several reports clearly suggest that NIK is not involved in TAK1-induced IKK activation and TAK1 is a direct upstream kinase phosphorylating IKK in HeLa cells treated with IL-1 , Ninomiya-Tsuji et al. showed that NIK is a mediator of TAK1-induced IKK activation in IL-1-treated 293 cells. It is unclear whether this discrepancy is due to the cell type or subtle differences in overexpression of the dominant-negative inactive NIK mutant.

7. Other Kinases

A variety of other kinases have been reported to function upstream of IKK. Because of the lack of evidence of direct association of these kinases with IKK upon activation or specific phosphorylation site(s) of these kinases on IKK, it is unclear whether these kinases are direct upstream kinases phosphorylating and activating of IKK, or far more distal kinases indirectly activating IKK. These kinases include Cot , PKCz, PKCa , PKCq , or PKR etc. In light of the fact that a variety of kinases can affect IKK, it seems likely that different cell types and stimuli may utilize distinct upstream kinases for the activation of IKK. An example to support this notion is the observation that PKCq and Cot kinase participate in CD3-CD28 costimulation signal-induced, but not TNFa- induced, activation of NF-kB .

III. Mechanisms of Ubiquitination in NF-kB Activation

As detailed above, the activation of NF-kB by most of the extracellular inducers is dependent on the phosphorylation and subsequent degradation of IkB proteins. A crucial step during this process is the phosphorylation-dependent conjugation of IkB proteins with polyubiquitin chain, a marker required for the proteasomal degradation of IkBa. Whereas the ubiquitination sites on IkBb and IkBe have not been definitely identified , lysines 21 and 22 (K21 and K22) on the IkBa protein were considered as the major sites conjugated by the polyubiquitin chain .

Figure 2 : SCF-b-TrCP ubiquitin ligase complex-mediated ubiquitination of IkB proteins. The basic components of this E3 complex include Skp1, Cul-1 (CDC53), and the F-box protein, b-TrCP. b-TrCP recognizes and links the phosphorylated IkB proteins to this complex allowing the ubiquitination of IkBs by ubiquitin-conjugating enzyme E2 following the C-terminal G residue activation of ubiquitin by ubiquitin- activating enzyme E1.

Ubiquitin is a highly conserved and heat stable 76- amino acid protein found in virtually all types of eukaryotic cells . Ubiquitination of proteins involves three or four sequential steps (Fig. 2). Initially, the C-terminal glycine (G76) of ubiquitin is activated by ATP to form a high energy thiolester intermediate catalyzed by the ubiquitin-activating enzyme (Uba or E1). Activated ubiquitin is then transferred from E1 to one of many distinct ubiquitin-conjugating enzymes (Ubc or E2), forming a similar thioester-linked complex. Finally, with the aid of ubiquitin ligases (E3), an isopeptide bond is formed between the activated C-terminal G76 of ubiquitin and an e-NH2 group of a K residue of the substrate. In successive reactions, polyubiquitin chain, is synthesized by progressive transfer of ubiquitin moieties to K48 or K63 of the previously conjugated ubiquitin molecule, forming G76-K48 or G76-K63 isopeptide bonds. An assembly factor, named Ufd or E4, may be required for this process . The specificity of protein ubiquitination is usually determined by the ubiquitin ligase E3 that recognizes specific substrates. At least three types of ubiquitin ligase E3 complexes have been well documented. These ligase complexes include the Skp1-cullin-F-box (SCF) complex, the VHL protein-elongin B-elongin complex (VBC), and the anaphase promoting complex (APC). The ubiquitin ligase E3, responsible for the ubiquitination of IkBa, is the SCF complex containing a F-box/Trp-Asp repeating (WD) protein named b-TrCP (Fig. 2). Following phosphorylation of S32 and S36 in the conserved DSGXXS motif of IkBa by IKK, the b-TrCP subunit of the SCF complex recognizes and binds to the phosphorylated DSGXXS motif of IkBa . The binding of SCF to IkBa results in the association of SCF with specific E2s, including Ubc3, Ubc4, Ubc5, and Ubc9 . These E2s are able to catalyze the ubiquitin conjugation of IkBa and the assembly of G76-K48 polyubuquitin chain. Consistent with the likely role for SCF-b-TrCP as a ubiquitin ligase complex conjugating polyubiquitin chain to IkBa, is the observation that Slimb protein, a Drosophila homology of mammalian b-TrCP, is required for the ubiquitination of Cactus, an IkB-like protein inhibiting the activation of the Drosophila NF-kB homolog, Dorsal . During dorsoventral patterning of the early Drosophila embryo, the Dorsal protein is activated specifically on the ventral side of the embryo by the Toll receptor-signaling pathway. These findings point to the existence of an evolutionarily conserved pathway for specific ubiquitination of the IkBa protein for the purpose of dynamic signal transduction from the receptor to NF-kB.

In parallel studies of signal-induced IkBa ubiquitination, several reports indicated that this process could be antagonized by SUMO-1 (small ubiquitin-related modifier-1) modification of IkBa on the same residues where the polyubiquitin chain is conjugated , or by unknown product(s) of nonpathogenic Salmonella bacteria . SUMO-1 is one of the best-characterized members of ubiquitin-related proteins. Conjugation of SUMO-1 to substrates requires SUMO-1-activating enzyme Aos/Uba2, and SUMO-1-conjugating enzyme, Ubc9. Although substrates can be modified by several SUMO-1 at distinct sites, no multi-SUMO-1 chains are apparently formed . In contrast to ubiquitination of IkBa protein, SUMO-1 conjugation does not target IkBa to proteasomal degradation . The inhibition of NF-kB by certain bacterial pathogens may be through a mechanism affecting the conjugation of SUMO-1 on IkB proteins. One example is the observation that YopJ, a protein product encoded by a 70-kB plasmid harbored in the Yersinia species that caused the Black Death in the Middle Ages, inhibits MEKK1-induced NF-kB activation. Earlier study by Orth et al. indicated that the inhibition of NF-kB by YopJ is through direct interaction of YopJ with IKKb but not with IKKa. Structural analysis of YopJ protein by the same group later suggested that YopJ might be a SUMO-protease promoting the conversion of precursor SUMO-1 to mature SUMO-1 . Nevertheless, whether YopJ enhances the conjugation of SUMO-1 on IkBa has not been demonstrated.

The vast majority of ubiquitination reactions in which the proteins are ubiquitinated via G76-K48 assembly of the polyubiquitin chain target protein for proteasomal degradation. Examples include the ubiquitination of IkBa, p53, cyclins, c- Jun, and others. This is not, however, the case of ubiquitination of proteins via G76-K63 assembly of polyubiquitin chain. The biochemical evidence of G76-K63 assembly of the polyubiquitin chain remains elusive, but it appears to be independent of proteasomal degradation . Recent studies by Wang et al. suggest that linkage of the G76-K63 polyubiquitin chain with TRAF6 protein plays an important role in mediating TLR/IL-1R signal-induced activation of TAK1, an upstream kinase of IKK. TRAF6 itself exhibits the ubiquitin ligase E3 activity by the structural characteristic of RING fingers in its C-terminus.

The nature of the upstream regulators that promote G76-K63 ubiquitination of TRAF6 is less clear. One good candidate, however, is the Ubc complex composed of Ubc13, a member of the ubiquitin-conjugating enzyme E2 family, and Uev1A, a ubiquitin- conjugating E2 enzyme variant . In yeast and mammalian cells, both Ubc13 and Uev1A are considered the major enzymes required for the synthesis of G76-K63 polyubiquitin . In chromatographic purification of HeLa cell cytoplasmic extracts, the Ubc13/Uev1A complex was found to be co-eluted with TRAF6 and appeared to be essential in TRAF6- induced TAK1 and subsequent IKK activation . However, in Drosophila, this Ubc13/Uev1A-induced K63 polyubiquitination of TRAF6 has yet to be established, despite the identification of the Drosophila homologs of Ubc13 and Uev1A, bendless and dUev1A, respectively . Interestingly, Ubc13/Uev1A was also found to interact genetically with a DNA repair protein, Rad5 , indicating that it is likely to be coupled to a number of cellular processes. Such a finding supports the likelihood that the activation of the Ubc complex provides a mechanism by which IKK signals can be selectively activated during cellular damage response in vivo.

IV. ROIs: Critical Mediators or bystanders in NF-kB Activation?

Oxidative stress is a hallmark of pathophysiological response resulting from the alterations of cellular redox homoeostasis due to either an over-production of reactive oxygen intermediates (ROIs) or a deficiency in buffering or scavenging system for ROIs . Typically, the oxidatively stressed cells exhibit damage of their macromolecules leading to lipid peroxidation, oxidation of amino acid side chains (especially cysteine), DNA damage, stress response kinase activation and gene expression associated with cell cycle arrest and/or cell apoptosis. Moderate oxidative stress without severe damage of structural and functional macromolecules can be recovered due to the activation of cellular defense systems including nonenzymatic and enzymatic antioxidants. A number of stress response genes are induced to protect cells from the oxidative stress or to repair the ROI-mediated damages. A sustained oxidative stress produced during chronic or acute inflammatory response and/on environmental toxicant exposure, however, will be cytotoxic.

Among all the known oxidative stress inducers, H2O2 and some environmental toxic metals or particles are perhaps the most potent and well studied . Many other agents, such as TNFa, IL-1 and bacterial or viral proteins, also induce oxidative stress . Since the discovery of NF-kB, hundreds of reports have indicated that some extracellular stimuli that induce oxidative stress also activate NF-kB . Thus, it is not too surprising that many researchers attributed a role for ROIs in signal- induced NF-kB activation . Some even proposed that ROIs might be universal molecules mediating the activation of NF-kB in response to a broad range of stimuli . However, the conclusion that ROIs mediate NF-kB activation has been strongly challenged . First, correlations between ROI generation and NF-kB activation do not necessarily mean ROIs are essential mediators linking upstream signals to NF-kB activation. Under certain circumstances, ROI generation may be simply a bystander signal or a secondary response to NF-kB activation. Second, caution should be exercised in interpreting the inhibitory effects of a various antioxidants on signal-induced NF-kB. Many antioxidants can disturb the normal cellular redox status that maintains the basal signaling potential required for the activation of NF-kB or other intracellular biochemical events even under the non-oxidative stress conditions. In addition, many low-molecular-weight antioxidants may inhibit NF-kB by non-antioxidant actions . Third, it should be noted that several studies show that ROIs fail to activate NF-kB in many experimental systems . Finally, emerging evidence suggests that the DNA binding activity of activated and nuclear translocated NF-kB requires reducing conditions . Oxidation or nitrosylation of the cysteine residue in the DNA binding domain of the NF-kB p50 subunit suppresses the DNA binding and transcriptional activity of NF-kB .

The signal transduction pathway, such as the upstream and proximal kinases, leading to the activation of NF-kB by TNF, IL-1, Toll, LPS, and CD28, has been clearly identified. However, only limited information is available to suggest the responsiveness of these kinases to ROIs . The evidence to implicate ROIs as stimulators of IKK is based on the elevated IKK activity in human epithelial cells or mouse fibroblast cells by the H2O2 treatment . In our own studies, we found a modest induction of IKK activity in cellular response to chromium(VI), a potent intracellular H2O2 inducer (Chen et al., unpublished). Nevertheless, studies challenging this observation exist. Li and Karin could not detect IKK kinase activity in HeLa cells stimulated with UV-C, another intracellular H2O2 inducer , despite the fact that UV-C induced IkBa degradation and NF-kB DNA binding. Similarly, Korn et al. described that H2O2 itself failed to stimulate IKK, but rather, inhibited TNFa-induced IKK activity. It is highly likely that H2O2 inactivates IKK through direct oxidation of a conserved cysteine 179 (C179) in the kinase domain of IKKb, a mechanism similar to the inactivation of IKKb by 15d-PGJ2 and a high concentration of arsenic .

Figure 3 : Model for the ROI-induced oxidation of Trx and the subsequent ubiquitination of IkBs. Oxidation of the C-X-X-C motif of Trx induces its dissociation from ASK1, thereby allowing the dimerization and activation of ASK1. JNK is activated by SEK1 that has been phosphorylated by ASK1, leading to the accumulation of b-TrCP which is required for the processes of IkB ubiquitination.

Whereas IKK seems to be a less favorable target- point in ROI-modulated NF-kB activation, kinases other than IKK may serve as bridge molecules linking ROIs to the activating signals of NF-kB. One such kinase, JNK, merits special attention, not only because of its unequivocal activation in response to ROIs, but also because of its potential link to the ubiquitination and subsequent degradation of IkBa . The activation of JNK by ROIs appears to be mediated by the activation of ASK1, a member of the MAPKKK family that phosphorylates and activates SEK1 (MKK4), an upstream kinase of JNK (Fig. 3). In resting cells, ASK1 binds with high affinity to the reduced form of thioredoxin (Trx) which serves as an inhibitor of ASK1 by preventing the dimerization of ASK1 . Oxidation of the C-X-X-C motif of Trx by ROIs induces the dissociation of Trx from ASK1, thereby allowing the dimerization of ASK1 and the consequent activation of JNK. We have previously reported that inhibition of JNK by overexpression of a dominant negative SEK1 impaired the degradation of IkBa and the activation of NF-kB induced by vanadate . This observation was further substantiated by Spiegelman et al. who provided convincing evidence indicating the contribution of JNK to the signal-induced ubiquitination of IkBa protein. Activation of JNK resulted in accumulation of b-TrCP, a subunit of the SCF-b-TrCP complex that recognizes the phosphorylates DSGXXS motif within the IkBa protein and causes the subsequent ubiquitination . While JNK has been implicated in the stabilization of a number of short-lived mRNAs in response to stress , it is plausible to speculate that the JNK-mediated accumulation of b-TrCP is through stabilization of the b-TrCP mRNA. Indeed, analysis of the b-TrCP mRNA sequence by Spiegelman et al. revealed a closely resembled JNK response element in addition to two AU-rich elements in the 3’-UTR region of b-TrCP mRNA. Since ubiquitination of the IkBa protein is potentially a rate-limiting step, the abundance of b-TrCP regulated by JNK may serve as an important point of regulation in ROI-induced NF-kB activation.

Table 1: Confirmed and putative IKK substrates in mammalian cells.

Substrates Consensus sitesReferences
Confirmed substrates:   
IkBa31D S G L D S3
IkBb18D S G L G S3
IkBe17D S G I E S3
70D S T Y G S 
p105921D S V C D S22
925D S G V E T23
p65535S S I A D M24
b-Catenin32D S G I H S10
Putative substrates:   
Rho-GEF220D S G L D S 
CDC2-related kinase 7439D S G L E S 
Centaurin b2386D S G N E S 
HNF-3a35 N S G L G S 
Metastasis suppressor protein321D S G F I S 
PPARg coactivator 160 D S G F V S 
TRAF6285D S G Y I S 
hIRS-1423D g G F I S 
Plakoglobin23 D S G I H S 
Carboxypeptidase A1175D T G I H S 
C-Met oncogene284DS G L H S 
RAD51 associated protein 118D S G N D S 
Chromodomain helicase53D S G S E S 
TNFR272 D T V C D S 
Tight junction protein 1 (ZO1)810D S G V E T 
Pannexin 2265D S G V Q T 
Eps8809D S G V E S 

Summary

Increasing evidence implicates dysregulation of signaling pathways leading to the activation of the NF-kB transcription factor in the pathology of various diseases, including autoimmune diseases, neurodegenerative diseases, inflammation, and cancers . Moreover, several human diseases due to the inherited mutations in the genes encoding NF-kB signaling molecules have been recently described . The signal transduction pathways of NF-kB activation therefore represent potential targets for therapeutic intervention. As discussed above, tremendous advances have been made in our understanding of the upstream signaling pathways of NF-kB activation. Yet this understanding is not complete. A fundamental goal for future studies is to focus on the structural and functional aspects of the participating components in these pathways. It seems likely that new aspects of NF-kB signaling will be discovered through such studies.

1Abbreviations:

IKK, IkB kinase complex; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinases; ROIs, reactive oxygen intermediates; NIK, NF-kB inducing kinase; NAK, NF-kB activating kinase; TAK1, TGF-b activating kinase 1; MLK, mixed lineage kinase.

Acknowledgments

We thank our colleague Drs Murali Rao and Vince Castranova for helpful suggestions and critique of the manuscript. We apologize to those whose primary valuable work was not cited because of space limitation. Dr. Fei Chen thanks the Health Effects Laboratory Division/National Institute for Occupational Safety and Health for its continuing supporting.

Bibliography

Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway.
Anderson MT, Staal FJ, Gitler C, Herzenberg LA, Herzenberg LA
Proceedings of the National Academy of Sciences of the United States of America. 1994 ; 91 (24) : 11527-11531.
PMID 7526398
 
NF-kappaB signaling and human disease.
Aradhya S, Nelson DL
Current opinion in genetics & development. 2001 ; 11 (3) : 300-306.
PMID 11377967
 
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).
Aradhya S, Courtois G, Rajkovic A, Lewis RA, Levy M, Israël A, Nelson DL
American journal of human genetics. 2001 ; 68 (3) : 765-771.
PMID 11179023
 
Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha.
Baldi L, Brown K, Franzoso G, Siebenlist U
The Journal of biological chemistry. 1996 ; 271 (1) : 376-379.
PMID 8550590
 
The NF-kappa B and I kappa B proteins: new discoveries and insights.
Baldwin AS Jr
Annual review of immunology. 1996 ; 14 : 649-683.
PMID 8717528
 
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
Beg AA, Baldwin AS Jr
Genes & development. 1993 ; 7 (11) : 2064-2070.
PMID 8224838
 
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.
Bonizzi G, Piette J, Merville MP, Bours V
Biochemical pharmacology. 2000 ; 59 (1) : 7-11.
PMID 10605929
 
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.
Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V
Molecular and cellular biology. 1999 ; 19 (3) : 1950-1960.
PMID 10022882
 
Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.
Bowie A, O'Neill LA
Biochemical pharmacology. 2000 ; 59 (1) : 13-23.
PMID 10605930
 
Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals.
Brennan P, O'Neill LA
Biochimica et biophysica acta. 1995 ; 1260 (2) : 167-175.
PMID 7841193
 
Mammalian MAP kinase signalling cascades.
Chang L, Karin M
Nature. 2001 ; 410 (6824) : 37-40.
PMID 11242034
 
Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.
Chen CY, Del Gatto-Konczak F, Wu Z, Karin M
Science (New York, N.Y.). 1998 ; 280 (5371) : 1945-1949.
PMID 9632395
 
New insights into the role of nuclear factor-kappaB in cell growth regulation.
Chen F, Castranova V, Shi X
The American journal of pathology. 2001 ; 159 (2) : 387-397.
PMID 11485895
 
Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages.
Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, Shi X
The Journal of biological chemistry. 1999 ; 274 (29) : 20307-20312.
PMID 10400652
 
Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages.
Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM
Biochemical and biophysical research communications. 1995 ; 214 (3) : 839-846.
PMID 7575553
 
Chen K, Vita J A, Berk B C, Keaney J F Jr
J Biol Chem. 2001 ; 276 (19) : 16045-16050.
 
Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.
Chen YR, Shrivastava A, Tan TH
Oncogene. 2001 ; 20 (3) : 367-374.
PMID 11313966
 
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T
Genes & development. 1995 ; 9 (13) : 1586-1597.
PMID 7628694
 
IKAP is a scaffold protein of the IkappaB kinase complex.
Cohen L, Henzel WJ, Baeuerle PA
Nature. 1998 ; 395 (6699) : 292-296.
PMID 9751059
 
Oxidative stress: the paradox of aerobic life.
Davies KJ
Biochemical Society symposium. 1995 ; 61 : 1-31.
PMID 8660387
 
Kinase regulation in inflammatory response.
Delhase M, Li N, Karin M
Nature. 2000 ; 406 (6794) : 367-368.
PMID 10935625
 
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ
Cell. 2000 ; 103 (2) : 351-361.
PMID 11057907
 
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
Desterro JM, Rodriguez MS, Hay RT
Molecular cell. 1998 ; 2 (2) : 233-239.
PMID 9734360
 
Oxidants, oxidative stress and the biology of ageing.
Finkel T, Holbrook NJ
Nature. 2000 ; 408 (6809) : 239-247.
PMID 11089981
 
Redox regulation of NF-kappa B activation.
Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L
Free radical biology & medicine. 1997 ; 22 (6) : 1115-1126.
PMID 9034250
 
Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction.
Gotoh Y, Cooper JA
The Journal of biological chemistry. 1998 ; 273 (28) : 17477-17482.
PMID 9651337
 
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1.
Hatakeyama S, Kitagawa M, Nakayama K, Shirane M, Matsumoto M, Hattori K, Higashi H, Nakano H, Okumura K, Onoé K, Good RA, Nakayama K
Proceedings of the National Academy of Sciences of the United States of America. 1999 ; 96 (7) : 3859-3863.
PMID 10097128
 
Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.
Hayashi T, Ueno Y, Okamoto T
The Journal of biological chemistry. 1993 ; 268 (15) : 11380-11388.
PMID 8496188
 
Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex.
Hehner SP, Hofmann TG, Ushmorov A, Dienz O, Wing-Lan Leung I, Lassam N, Scheidereit C, Dröge W, Schmitz ML
Molecular and cellular biology. 2000 ; 20 (7) : 2556-2568.
PMID 10713178
 
NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C
The EMBO journal. 1999 ; 18 (17) : 4766-4778.
PMID 10469655
 
Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.
Hofmann RM, Pickart CM
Cell. 1999 ; 96 (5) : 645-653.
PMID 10089880
 
In vitro assembly and recognition of Lys-63 polyubiquitin chains.
Hofmann RM, Pickart CM
The Journal of biological chemistry. 2001 ; 276 (30) : 27936-27943.
PMID 11369780
 
Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase.
Holmes-McNary M, Baldwin AS Jr
Cancer research. 2000 ; 60 (13) : 3477-3483.
PMID 10910059
 
IKKalpha controls formation of the epidermis independently of NF-kappaB.
Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M
Nature. 2001 ; 410 (6829) : 710-714.
PMID 11287960
 
UV activates growth factor receptors via reactive oxygen intermediates.
Huang RP, Wu JX, Fan Y, Adamson ED
The Journal of cell biology. 1996 ; 133 (1) : 211-220.
PMID 8601609
 
The IKK complex: an integrator of all signals that activate NF-kappaB?
Israë A
Trends in cell biology. 2000 ; 10 (4) : 129-133.
PMID 10740266
 
Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines.
Israël N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL
Journal of immunology (Baltimore, Md. : 1950). 1992 ; 149 (10) : 3386-3393.
PMID 1431113
 
Hydrogen peroxide has opposing effects on IKK activity and IkappaBalpha breakdown in airway epithelial cells.
Jaspers I, Zhang W, Fraser A, Samet JM, Reed W
American journal of respiratory cell and molecular biology. 2001 ; 24 (6) : 769-777.
PMID 11415944
 
PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.
Jiang C, Ting AT, Seed B
Nature. 1998 ; 391 (6662) : 82-86.
PMID 9422509
 
Induction of NF-kappaB by the Akt/PKB kinase.
Kane LP, Shapiro VS, Stokoe D, Weiss A
Current biology : CB. 1999 ; 9 (11) : 601-604.
PMID 10359702
 
Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase.
Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY, Karin M
The Journal of biological chemistry. 2000 ; 275 (46) : 36062-36066.
PMID 10967126
 
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M, Ben-Neriah Y
Annual review of immunology. 2000 ; 18 : 621-663.
PMID 10837071
 
Akt is more than just a Bad kinase.
Khwaja A
Nature. 1999 ; 401 (6748) : 33-34.
PMID 10485701
 
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M
The Journal of experimental medicine. 1998 ; 188 (11) : 2091-2097.
PMID 9841923
 
A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.
Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S
Cell. 1999 ; 96 (5) : 635-644.
PMID 10089879
 
Inhibition of NF-kappa B by sodium salicylate and aspirin.
Kopp E, Ghosh S
Science (New York, N.Y.). 1994 ; 265 (5174) : 956-959.
PMID 8052854
 
NF-kappa B and rel proteins in innate immunity.
Kopp EB, Ghosh S
Advances in immunology. 1995 ; 58 : 1-27.
PMID 7741027
 
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.
Kopp E, Medzhitov R, Carothers J, Xiao C, Douglas I, Janeway CA, Ghosh S
Genes & development. 1999 ; 13 (16) : 2059-2071.
PMID 10465784
 
Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase.
Korn SH, Wouters EF, Vos N, Janssen-Heininger YM
The Journal of biological chemistry. 2001 ; 276 (38) : 35693-35700.
PMID 11479295
 
Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.
Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R
The Journal of biological chemistry. 1999 ; 274 (12) : 7941-7945.
PMID 10075690
 
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM
Chemistry & biology. 2001 ; 8 (8) : 759-766.
PMID 11514225
 
Activation of IkappaB kinase beta by protein kinase C isoforms.
Lallena MJ, Diaz-Meco MT, Bren G, Pay´ CV, Moscat J
Molecular and cellular biology. 1999 ; 19 (3) : 2180-2188.
PMID 10022904
 
Lamberti C, Lin K M, Yamamoto Y, Verma U, Verma I M, Byers S, Gaynor R B
J Biol Chem. 2001 ; 29 : page 29.
 
Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.
Lee FS, Hagler J, Chen ZJ, Maniatis T
Cell. 1997 ; 88 (2) : 213-222.
PMID 9008162
 
Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
Li N, Karin M
Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (22) : 13012-13017.
PMID 9789032
 
Is NF-kappaB the sensor of oxidative stress?
Li N, Karin M
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 1999 ; 13 (10) : 1137-1143.
PMID 10385605
 
The human T-cell leukemia virus type-1 Tax protein regulates the activity of the IkappaB kinase complex.
Li XH, Murphy KM, Palka KT, Surabhi RM, Gaynor RB
The Journal of biological chemistry. 1999 ; 274 (48) : 34417-34424.
PMID 10567421
 
The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.
Lin X, Cunningham ET Jr, Mu Y, Geleziunas R, Greene WC
Immunity. 1999 ; 10 (2) : 271-280.
PMID 10072079
 
Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta.
Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC
Molecular and cellular biology. 2000 ; 20 (8) : 2933-2940.
PMID 10733597
 
NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.
Ling L, Cao Z, Goeddel DV
Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (7) : 3792-3797.
PMID 9520446
 
Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin.
Liu H, Nishitoh H, Ichijo H, Kyriakis JM
Molecular and cellular biology. 2000 ; 20 (6) : 2198-2208.
PMID 10688666
 
A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
Madge LA, Pober JS
The Journal of biological chemistry. 2000 ; 275 (20) : 15458-15465.
PMID 10748004
 
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.
Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW
Molecular and cellular biology. 2000 ; 20 (5) : 1626-1638.
PMID 10669740
 
MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.
Malinin NL, Boldin MP, Kovalenko AV, Wallach D
Nature. 1997 ; 385 (6616) : 540-544.
PMID 9020361
 
Nitrosation and oxidation in the regulation of gene expression.
Marshall HE, Merchant K, Stamler JS
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2000 ; 14 (13) : 1889-1900.
PMID 11023973
 
Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.
Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT
Nucleic acids research. 1992 ; 20 (15) : 3821-3830.
PMID 1508666
 
SUMO--nonclassical ubiquitin.
Melchior F
Annual review of cell and developmental biology. 2000 ; 16 : 591-626.
PMID 11031248
 
Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver.
Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE
Proceedings of the National Academy of Sciences of the United States of America. 1996 ; 93 (23) : 12908-12913.
PMID 8917518
 
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A
Science (New York, N.Y.). 1997 ; 278 (5339) : 860-866.
PMID 9346484
 
Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.
Minden A, Lin A, McMahon M, Lange-Carter C, Dérijard B, Davis RJ, Johnson GL, Karin M
Science (New York, N.Y.). 1994 ; 266 (5191) : 1719-1723.
PMID 7992057
 
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6).
Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A
The Journal of experimental medicine. 1998 ; 187 (12) : 2097-2101.
PMID 9625770
 
Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1.
Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K
Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (7) : 3537-3542.
PMID 9520401
 
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.
Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL
Science (New York, N.Y.). 2000 ; 289 (5484) : 1560-1563.
PMID 10968793
 
The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K
Nature. 1999 ; 398 (6724) : 252-256.
PMID 10094049
 
NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.
Nomura F, Kawai T, Nakanishi K, Akira S
Genes to cells : devoted to molecular & cellular mechanisms. 2000 ; 5 (3) : 191-202.
PMID 10759890
 
Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.
Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE
Science (New York, N.Y.). 1999 ; 285 (5435) : 1920-1923.
PMID 10489373
 
Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE
Science (New York, N.Y.). 2000 ; 290 (5496) : 1594-1597.
PMID 11090361
 
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB
Nature. 1999 ; 401 (6748) : 82-85.
PMID 10485710
 
Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability.
Pagès G, Berra E, Milanini J, Levy AP, Pouysségur J
The Journal of biological chemistry. 2000 ; 275 (34) : 26484-26491.
PMID 10849421
 
A new family of IKK-related kinases may function as I kappa B kinase kinases.
Peters RT, Maniatis T
Biochimica et biophysica acta. 2001 ; 1471 (2) : M57-M62.
PMID 11342184
 
IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex.
Peters RT, Liao SM, Maniatis T
Molecular cell. 2000 ; 5 (3) : 513-522.
PMID 10882136
 
Kinase phosphorylation: Keeping it all in the family.
Peterson RT, Schreiber SL
Current biology : CB. 1999 ; 9 (14) : R521-R524.
PMID 10421571
 
Mechanisms underlying ubiquitination.
Pickart CM
Annual review of biochemistry. 2001 ; 70 : 503-533.
PMID 11395416
 
NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL, Baltimore D
The EMBO journal. 1999 ; 18 (23) : 6694-6704.
PMID 10581243
 
Phosphorylation and activation of p70s6k by PDK1.
Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G
Science (New York, N.Y.). 1998 ; 279 (5351) : 707-710.
PMID 9445476
 
PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts.
Rauch BH, Weber A, Braun M, Zimmermann N, Schrör K
FEBS letters. 2000 ; 481 (1) : 3-7.
PMID 10984605
 
Redox signaling: hydrogen peroxide as intracellular messenger.
Rhee SG
Experimental & molecular medicine. 1999 ; 31 (2) : 53-59.
PMID 10410302
 
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK
Nature. 1998 ; 391 (6662) : 79-82.
PMID 9422508
 
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.
Romashkova JA, Makarov SS
Nature. 1999 ; 401 (6748) : 86-90.
PMID 10485711
 
Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation.
Rossi A, Elia G, Santoro MG
Proceedings of the National Academy of Sciences of the United States of America. 1997 ; 94 (2) : 746-750.
PMID 9012856
 
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG
Nature. 2000 ; 403 (6765) : 103-108.
PMID 10638762
 
IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.
Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W
The Journal of biological chemistry. 1999 ; 274 (43) : 30353-30356.
PMID 10521409
 
Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation.
Sakurai H, Miyoshi H, Toriumi W, Sugita T
The Journal of biological chemistry. 1999 ; 274 (15) : 10641-10648.
PMID 10187861
 
TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism.
Sakurai H, Shigemori N, Hasegawa K, Sugita T
Biochemical and biophysical research communications. 1998 ; 243 (2) : 545-549.
PMID 9480845
 
Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis.
Salmerón A, Janzen J, Soneji Y, Bump N, Kamens J, Allen H, Ley SC
The Journal of biological chemistry. 2001 ; 276 (25) : 22215-22222.
PMID 11297557
 
Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism.
Salnikow K, Su W, Blagosklonny MV, Costa M
Cancer research. 2000 ; 60 (13) : 3375-3378.
PMID 10910041
 
Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.
Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr, Ritchie TC, Hunninghake GW, Zandi E, Engelhardt JF
The Journal of biological chemistry. 2001 ; 276 (32) : 30188-30198.
PMID 11402028
 
The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B.
Schmidt KN, Amstad P, Cerutti P, Baeuerle PA
Chemistry & biology. 1995 ; 2 (1) : 13-22.
PMID 9383399
 
NEMO/IKK gamma-deficient mice model incontinentia pigmenti.
Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israël A, Rajewsky K, Pasparakis M
Molecular cell. 2000 ; 5 (6) : 981-992.
PMID 10911992
 
Oxidative stress interference with the nuclear factor-kappa B activation pathways.
Schoonbroodt S, Piette J
Biochemical pharmacology. 2000 ; 60 (8) : 1075-1083.
PMID 11007944
 
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.
Schreck R, Rieber P, Baeuerle PA
The EMBO journal. 1991 ; 10 (8) : 2247-2258.
PMID 2065663
 
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
Sen R, Baltimore D
Cell. 1986 ; 47 (6) : 921-928.
PMID 3096580
 
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M
Science (New York, N.Y.). 2001 ; 293 (5534) : 1495-1499.
PMID 11520989
 
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.
Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S
International immunology. 1999 ; 11 (8) : 1357-1362.
PMID 10421793
 
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase.
Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, Suzuki M, Kogishi K, Serikawa T, Honjo T
Nature genetics. 1999 ; 22 (1) : 74-77.
PMID 10319865
 
Common pathway for the ubiquitination of IkappaBalpha, IkappaBbeta, and IkappaBepsilon mediated by the F-box protein FWD1.
Shirane M, Hatakeyama S, Hattori K, Nakayama K, Nakayama K
The Journal of biological chemistry. 1999 ; 274 (40) : 28169-28174.
PMID 10497169
 
NF-kappaB signaling pathways in mammalian and insect innate immunity.
Silverman N, Maniatis T
Genes & development. 2001 ; 15 (18) : 2321-2342.
PMID 11562344
 
Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit.
Sizemore N, Leung S, Stark GR
Molecular and cellular biology. 1999 ; 19 (7) : 4798-4805.
PMID 10373529
 
A ubiquitin mutant with specific defects in DNA repair and multiubiquitination.
Spence J, Sadis S, Haas AL, Finley D
Molecular and cellular biology. 1995 ; 15 (3) : 1265-1273.
PMID 7862120
 
Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.
Spencer E, Jiang J, Chen ZJ
Genes & development. 1999 ; 13 (3) : 284-294.
PMID 9990853
 
Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor.
Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY
Molecular cell. 2000 ; 5 (5) : 877-882.
PMID 10882123
 
Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB.
Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga TJ, Fuchs SY
The Journal of biological chemistry. 2001 ; 276 (29) : 27152-27158.
PMID 11375388
 
SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P, Caligiuri M, Pelletier M, Boisclair M, Theodoras A, Beer-Romero P, Glass S, Parsons T, Copeland RA, Auger KR, Benfield P, Brizuela L, Rolfe M
Oncogene. 2000 ; 19 (31) : 3529-3536.
PMID 10918611
 
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.
Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Annes J, Petrzilka D, Kupfer A, Schwartzberg PL, Littman DR
Nature. 2000 ; 404 (6776) : 402-407.
PMID 10746729
 
Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate.
Suzuki YJ, Packer L
Biochemistry and molecular biology international. 1993 ; 31 (4) : 693-700.
PMID 8298498
 
Oxidants as stimulators of signal transduction.
Suzuki YJ, Forman HJ, Sevanian A
Free radical biology & medicine. 1997 ; 22 (1-2) : 269-285.
PMID 8958153
 
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G
Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (17) : 10106-10111.
PMID 9707608
 
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.
Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K
Molecular cell. 2000 ; 5 (4) : 649-658.
PMID 10882101
 
Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha.
Tashiro K, Pando MP, Kanegae Y, Wamsley PM, Inoue S, Verma IM
Proceedings of the National Academy of Sciences of the United States of America. 1997 ; 94 (15) : 7862-7867.
PMID 9223278
 
Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family.
Teramoto H, Coso OA, Miyata H, Igishi T, Miki T, Gutkind JS
The Journal of biological chemistry. 1996 ; 271 (44) : 27225-27228.
PMID 8910292
 
Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M
Nature. 2000 ; 404 (6779) : 778-782.
 
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano MB, Leonard WJ
Proceedings of the National Academy of Sciences of the United States of America. 1991 ; 88 (10) : 4328-4332.
PMID 1903539
 
Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair.
Ulrich HD, Jentsch S
The EMBO journal. 2000 ; 19 (13) : 3388-3397.
PMID 10880451
 
Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses.
Vidal S, Khush RS, Leulier F, Tzou P, Nakamura M, Lemaitre B
Genes & development. 2001 ; 15 (15) : 1900-1912.
PMID 11485985
 
Wang C, Deng L, Hong M, Akkaraju G R, Inoue J, Chen Z J
Nature. 2001 ; 412 (6844) : 346-351.
 
Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha.
Weil R, Laurent-Winter C, Israël A
The Journal of biological chemistry. 1997 ; 272 (15) : 9942-9949.
PMID 9092533
 
The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW
Genes & development. 1999 ; 13 (3) : 270-283.
PMID 9990852
 
Woronicz J D, Gao X, Cao Z, Rothe M, Goeddel D V
Science. 1997 ; 278 (5339) : 866-869.
 
beta-TrCP mediates the signal-induced ubiquitination of IkappaBbeta.
Wu C, Ghosh S
The Journal of biological chemistry. 1999 ; 274 (42) : 29591-29594.
PMID 10514424
 
MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.
Xia Y, Makris C, Su B, Li E, Yang J, Nemerow GR, Karin M
Proceedings of the National Academy of Sciences of the United States of America. 2000 ; 97 (10) : 5243-5248.
PMID 10805784
 
Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt.
Xie P, Browning DD, Hay N, Mackman N, Ye RD
The Journal of biological chemistry. 2000 ; 275 (32) : 24907-24914.
PMID 10801799
 
Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K
Science. 1995 ; 270 (5244) : 2008-2011.
 
Sulindac inhibits activation of the NF-kappaB pathway.
Yamamoto Y, Yin MJ, Lin KM, Gaynor RB
The Journal of biological chemistry. 1999 ; 274 (38) : 27307-27314.
PMID 10480951
 
The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6.
Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW
Molecular pharmacology. 2001 ; 60 (3) : 528-533.
PMID 11502884
 
Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.
Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD
Science (New York, N.Y.). 2001 ; 291 (5511) : 2162-2165.
PMID 11251123
 
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.
Yin MJ, Yamamoto Y, Gaynor RB
Nature. 1998 ; 396 (6706) : 77-80.
PMID 9817203
 
Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases.
Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z
Cancer research. 2000 ; 60 (15) : 4053-4057.
PMID 10945608
 
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.
Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE
Science (New York, N.Y.). 2001 ; 293 (5535) : 1673-1677.
PMID 11533494
 
NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase.
Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR
Molecular and cellular biology. 2000 ; 20 (4) : 1278-1290.
PMID 10648614
 
The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M
Cell. 1997 ; 91 (2) : 243-252.
PMID 9346241
 
Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.
Zhang X, Wang JM, Gong WH, Mukaida N, Young HA
Journal of immunology (Baltimore, Md. : 1950). 2001 ; 166 (12) : 7104-7111.
PMID 11390455
 
Written2001-12Fei Chen, Jacquelyn Bower, Laurence M. Demers, Xianglin Shi
Effects Laboratory Division, NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505, USA

Citation

This paper should be referenced as such :
Chen, F ; Bower, J ; Demers, LM ; Shi, X
Upstream signal transduction of NF-kB activation
Atlas Genet Cytogenet Oncol Haematol. 2002;6(2):158-172.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Deep/NFKBID20033.htm

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Mar 14 13:58:08 CET 2017


Home   Genes    Leukemias    Solid Tumours    Cancer-Prone    Deep Insight    Case Reports    Journals   Portal    Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.